BACKGROUND: Although c-Kit + adult progenitor cells were initially reported to produce new cardiomyocytes in the heart, recent genetic evidence suggests that such events are exceedingly rare. However, to determine if these rare events represent true de novo cardiomyocyte formation, we deleted the necessary cardiogenic transcription factors Gata4 and Gata6 from c-Kit-expressing cardiac progenitor cells.
L arge-scale cardiomyocyte loss from a cardiac ischemic event initially elicits a dramatic inflammatory response, followed by fibroblast activation with scar formation and fibrosis, and then ventricular remodeling and eventually heart failure. 1 To combat this profile of progressive cardiac deterioration after ischemic injury, cell-specific approaches have emerged with emphasis on altering the hematopoietic response, 2 ameliorating fibrotic remodeling, [3] [4] [5] [6] increasing collateral circulation, 7, 8 and preserving or replacing cardiomyocytes. 9, 10 Earlier reports that endogenous cardiac stem cells exist and might be efficacious in mediating cardiac regeneration generated a great deal of excitement in the field. 11, 12 c-Kit + cardiac progenitor cells (CPCs), named for the presence of c-Kit tyrosine kinase receptor that marks hematopoietic stem cells, 13 have been the focus of numerous cardiac regenerative studies. [14] [15] [16] Select clinical trials evaluating the administration of bone marrow cells after myocardial infarction have shown minimal efficacy. [17] [18] [19] However, expanded cardiac c-Kit + cells were reported to potentially impart greater functional benefit with scar reduction when administered to patients post-myocardial infarction injury. 20, 21 Although injection of exogenously expanded CPCs may indeed positively impact the myocardial infarctioninjured heart, several recent studies have definitively shown that the heart lacks an endogenous c-Kit + CPC capable of producing new cardiomyocytes in vivo. [22] [23] [24] For example, we determined that endothelial cells are the major fate of Kit lineage-traced cells in the heart and that only 1 in 17 000 cardiomyocytes might be produced de novo when an 80% fusion rate is taken into account. 22 Sultana and colleagues 23 confirmed these results, demonstrating that a large proportion of lineage-traced Kit allele-derived cells are endothelial, whereas Kit allele lineage-traced cardiomyocytes coexpressing cardiac troponin T in the adult mouse heart were exceptionally rare. Furthermore, a novel Cre/Dre dual recombinase mouse genetic system by He and colleagues, 24 which no longer relies on the heterozygosity of the Kit allele, showed that c-Kit + cells never produce de novo cardiomyocytes in the adult heart at baseline or with injury. However, the potential to genetically reprogram c-Kit-derived cells and other cardiac mesenchymal cells into cardiomyocytes remains attractive for future development. 25, 26 The goal of the current study was to determine the contribution of true versus apparent Kit allele lineagederived cardiomyocytes by simultaneously deleting the cardiomyogenic transcription factors Gata4 and Gata6, which, when deleted from mesodermal progenitors during early development, results in acardia and absence of cardiomyocytes. 27 We report here that deletion of Gata4 from c-Kit + cells preferentially impacted a population of c-Kit-expressing endothelial cells and their differentiation state, resulting in defective cardiac capillary formation and immune cell infiltration, which secondarily resulted in a dramatically enhanced rate of fusion of c-Kit-derived immune cells with cardiomyocytes.
METHODS
An expanded Methods section is available in the online-only Data Supplement.
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure by contacting the corresponding author. The RNA sequencing data were deposited with the GEO database group and given accession number GSE109661.
Animals
All experiments involving mice were approved by the Institutional Animal Care and Use Committee at Cincinnati
Clinical Perspective

What Is New?
• This is the first study to genetically delete the necessary cardiogenic transcription factors Gata4/6 from c-Kit + cardiac progenitor cells, which remarkably resulted in greater apparent cardiomyocyte derivation from these c-Kit + cells. • Deletion of Gata4 from c-Kit-derived endothelial progenitors alters the integrity of the endothelial cell network in the heart, resulting in more c-Kit +derived leukocytes entering the heart and fusing with cardiomyocytes. • We demonstrate a new role for Gata4 in endothelial differentiation, specifically showing for the first time that Gata4 is essential for vascular development via the c-Kit lineage. • This study shows that leukocyte-to-cardiomyocyte fusion is the primary basis for past lineage-tracing results incorrectly suggesting that c-Kit + cardiac progenitor cells generated de novo cardiomyocytes in the heart.
What Are the Clinical Implications?
• Our data demonstrate that c-Kit + cardiac progenitor cells are much less likely to differentiate de novo into cardiomyocytes than previously reported, suggesting that such cells are not therapeutically meaningful as a source of new cardiomyocytes. • Our study highlights a capillary-driven mechanism of increased fusion of bone marrow-derived cells (leukocytes) with existing cardiomyocytes, which could have significant clinical implications in its own right. • Kit lineage and global endothelial cell deletion of Gata4 reveal apparent organ-specific regulation of microvascular differentiation, highlighting Gata4 as a potential target for angiogenic control in the human heart. ) , and Rosa26 lineage-dependent reporter mice, as well, were each previously described. 22 LoxP-targeted Gata4 (Gata4 fl ) and Gata6 (Gata6 fl ) mice were described previously. 28, 29 The endothelial specific Tie2 CreERT2 transgenic mouse model was described elsewhere (Y. Zheng and colleagues, unpublished data). 29a Detailed descriptions of tamoxifen-dosing procedures and euthanasia procedures are provided in the online-only Data Supplement.
Protein Analysis
Immunofluorescent stains were performed on cryoembedded tissues, 22 and Western blots were performed on cells isolated by fluorescence-activated cell sorting and whole cardiac ventricle tissue as described previously. 30 Descriptions of the antibodies used are provided in the online-only Data Supplement.
Vascular Endothelial Growth Factor-A Overexpression
An adeno-associated virus-9 vector expressing VEGF-A (vascular endothelial growth factor-A) was prepared and titered (online-only Data Supplement Methods). Adult C57Bl/6 mice were administered adeno-associated virus-9-VEGF-A by tail vein injection at concentration of 1×10 12 viral particles in 200 µL of sterile phosphate-buffered saline.
Bone Marrow Transplantation
Bone marrow transplantations were performed by transplanting bone marrow cells from 6-to 8-week-old donor mice into 8-to 10-week-old recipients. Bone marrow cells (BMCs) were isolated by aseptically flushing femurs and tibiae with Hanks' Balanced Salt Solution. Bone marrow transplant recipient mice first received lethal irradiation (12 Gy in a divided dose 4 hours apart 31 ) and then immediately received a tail vein injection of BMCs at ≈50 million per mouse in 200 µL of Hanks' Balanced Salt Solution.
Retinal Angiogenesis Assay
To observe the superficial vascular plexus to assess endothelial developmental defects, retinal flat mounts were prepared as described earlier. 5 In brief, postnatal day (p) 0 mice were given intraperitoneal injections of 200 μg tamoxifen (Sigma T5648; dissolved in 5 μL ethanol and 95 μL peanut oil) for gene inactivation and Tie2 (Tek gene) lineage tracing. Neonatal mice were euthanized, their eyes were harvested at p8 and fixed, and the retinas were dissected and mounted for qualitative comparison by enhanced green fluorescent protein (eGFP) fluorescence.
Flow Cytometry and Cell Sorting
Cells were prepared for flow cytometry studies on cardiac interstitial cells and BMCs as described in detail before. 4, 22, 32 BMCs and cardiac interstitial cells were stained with surface markers using allophycocyanin-conjugated antibodies, and optimum gating strategy was determined using singly labeled controls.
RNA Sequencing Analysis
Endothelial cells were collected as described above for RNA harvest and production of cDNA libraries for sequencing. Libraries were sequenced on the Illumina HiSeq2500 following the manufacturer's protocol. Selected genes were verified by quantitative polymerase chain reaction.
Statistics
See Methods in the online-only Data Supplement for an indepth description of statistics.
RESULTS
Kit Lineage-Specific Gata4-, Gata6-, and Gata4/6-Deleted Mice
To examine the hypothesis that the deletion of Gata4 and Gata6 from c-Kit + CPCs in the heart would block all de novo cardiomyocyte formation, we crossed Kit MCM mice with mice containing loxP site (fl)-targeted alleles for Gata4 and Gata6 ( Figure 1A ). Again, loss of both transcription factors should lead to the inability of CPCs to activate the cardiac transcriptional program required for cardiogenesis. 27, 33, 34 In addition, mice were bred to harbor either the Rosa26-loxP-stop-loxP-eGFP (R26 eGFP ) allele or the Rosa26-membrane-Tomato-loxP-Stop-loxP-membrane-eGFP allele 35 (R26 mT/mG ) to trace total Kit allele-derived cells in the heart and to examine fusion-derived cardiomyocytes, respectively ( Figure 1A ). Fusion is scored when both the m-eGFP and m-Tomato signals are observed in the same cardiomyocyte, whereas a de novo transdifferentiation event from a c-Kit + CPC would give cardiomyocytes that are only m-eGFP positive. After weaning, mice were put on tamoxifen food for continuous labeling of Kit lineage-derived cells ( Figure 1B ). Recombination of these loxP-targeted alleles was assessed by polymerase chain reaction on control and tamoxifen-treated mice, showing specific recombination ( Figure 1C ). Mice were euthanized after 1, 2, and 4 months of tamoxifen treatment for histological and flow cytometry analysis of heart and other tissues. Unexpectedly, total eGFP + cardiomyocytes were increased in mice with deletion of Gata4/6 or Gata4, but not Gata6 alone with ≈2-fold, 4-fold, and 10-fold increases at 1, 2, and 4 months, respectively ( Figure 1D through 1F). Dual reporter labeling in Gata4/6-and Gata4-deleted mice revealed significantly more fusionderived cardiomyocytes (91%-93%) versus 80% to 83% in Kit MCM R26 mT/mG controls ( Figure 1G and 1H). It is interesting to note that skeletal muscle showed the appearance of eGFP + -fused myofibers in Gata4/6-and Gata4-deleted Kit-lineage mice for the first time ( Figure  I in the online-only Data Supplement), whereas other known immune cell-based fusion-prone tissues such as the liver 36 ORIGINAL RESEARCH ARTICLE derived cells dramatically enhances the relative rate of apparent cardiomyocyte de novo formation, which is potentially attributable to augmented fusion of Kit allele-derived immune cells with tissue parenchymal cells as previously shown. 38, 39 Immunofluorescence staining of Gata4 was frequently positive in total aggregates of BMCs, which is also a known site of c-Kit expression as shown by lineage tracing from the Kit allele to produce eGFP expression ( Figure 2A ). It is interesting to note that CD133 + endothelial progenitor cells 40 from the bone marrow were dramatically enhanced in Kit allele-lineage Gata4/6-deleted mice in comparison with controls, possibly suggesting a functional role for Gata4 in endothelial cells ( Figure 2B ). Indeed, previous lineage tracing with the Kit Cre mouse model demonstrated that cardiac Kit-derived cell populations in the heart comprised 77% endothelial cells (CD31 + ) and 18% leukocytes (CD45 + ). 22 Western blotting of these populations for Gata4 protein demonstrated detectable expression in CD31 + endothelial cells but not in CD45 + leukocytes or total CD31 -CD45cardiac interstitial cells, or when Gata4 was deleted from CD31 + cells using a Tie2 CreERT2 transgene ( Figure 2C ). Flow cytometry analysis for CD45 + cell content in the hearts of Kit-lineage Gata4/6and Gata4-deleted mice after 4 months of tamoxifen showed a ≈50% increase in leukocytes ( Figure 2D and 2F) and a ≈60% increase in CD31 + endothelial cells in comparison with controls ( Figure 2E and 2G). Taken together, these results show a clear alteration of Kit allele-derived populations in the heart in the absence of Gata4, such as a dramatic increase in endothelial and CD45 cell content.
Bone Marrow Transplant to Identify Cardiovascular Impact of Kit-Lineage Gata4/6 Loss
We hypothesized that the increase in relative Kit allele lineage-traced eGFP + cardiomyocytes with Gata4/6 deletion was attributable to greater leukocyte activity or altered endothelial cell function. To test this hypothesis, we performed a bone marrow transplant that would isolate the impact of Gata4/6 effects from the hematopoietic compartment. Here, the donating bone marrow was from Kit MCM Gata4/6 fl/fl R26 eGFP mice (or controls not deleted for Gata4/6) that had already undergone full recombination with 6 weeks of prior tamoxifen treatment, 
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which would produce eGFP + circulating immune cells and even endothelial progenitors in recipients ( Figure 3A ). The recipient mice were in the R26 mT genetic background so endogenous cells could be parsed from eGFP + cells. Recipient mice were irradiated, then given the bone marrow transplant and allowed to reconstitute for 8 weeks (Figure 3A) . Full bone marrow niche reconstitution was confirmed with Kit-lineage R26 eGFP recombination ( Figure 3B ) and a general lack of native mTomato + bone marrow ( Figure 3C ). eGFP + cardiomyocytes were observed in the hearts of both control and Gata4/6-deleted bone marrow recipients at the same level, which was attributable to fusion because 100% of the cells were both eGFP + and mTomato + ( Figure 3D and 3E ). Furthermore, flow cytometry analysis of cardiac interstitial cells revealed no difference in total CD31 + cells ( Figure 3F ), demonstrating that Gata4/6-deleted bone marrow alone did not recapitulate the phenotype of endothelial expansion or the large relative increase in eGFP + cardiomyocytes observed in the standard Kit lineage-traced Gata4/6-deleted mice at baseline.
Next, we performed a reverse bone marrow transplant strategy. Recipient Kit MCM mice with or without Gata4/6 deletion were lethally irradiated at 8 weeks of age, whereafter they received control bone marrow from global R26 mT donors ( Figure 3G ). After 2 months of tamoxifen treatment, mice were euthanized, and cardiac sections were analyzed for mTomato + -traced cardiomyocytes within Gata4/6 Kit lineage-deleted hearts. The data show an ≈4-fold increase in bone marrow-dependent mTomato + cardiomyocytes with endogenous Kit allele-dependent Gata4/6 deletion in comparison with Gata4/6 wild-type controls, suggesting that it is the deletion of Gata4/6 within the existing heart cells that leads to greater apparent cardiomyocyte fusion/labeling ( Figure 3H ). It is important to note that Kit-lineage endothelial cell recombination in bone marrow recipient mice was not significantly changed from the ≈8% to 10% of total cardiac endothelium observed in both control and Gata4/6-deleted hearts, with and without bone marrow transplant ( Figure 3I ). Together, these experiments demonstrate that a Kit lineage-de- ORIGINAL RESEARCH ARTICLE rived cell source endogenous to the heart is the mechanistic basis for the increased ability of wild-type bone marrow progenitor-derived cells (leukocytes) to fuse with cardiomyocytes in vivo. Endothelial cells are the predominant Kit lineagederived cell type present in the heart, 22 suggesting the hypothesis that loss of Gata4/6 within endogenous cardiac endothelial cells might be mechanistically responsible for greater immune cell infiltration and fusion with cardiomyocytes. To test this hypothesis, we first attempted to alter the differentiation and permeability characteristics of endogenous cardiac endothelial cells by using VEGF-A. Previous work has shown that VEGF-A overexpression leads to weakening of endothelial junctions and increased permeability as these cells partially dedifferentiate or proliferate. 41, 42 Here, we used a VEGF-A adeno-associated virus-9 to overexpress this factor in the heart of Kit lineage-traced mice by tail vein injection ( Figure IIA 
Global Endothelial Deletion of Gata4
Despite the modest proportion of Kit allele-derived endothelium (≈10%), the loss of Gata4 in these cells of the heart appeared to cause a global cardiac phenotype of endothelial cell expansion, leukocyte infiltration, and heterotypic cardiomyocyte fusion, suggesting 
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that Kit allele-derived endothelial cells were critical in adult vascular maintenance. To further implicate endothelial cells as the causative cell type, we used a tamoxifen-inducible Tie2 Cre-expressing transgenic mouse (Tie2 CreERT2 ) to achieve a global and adult endothelial cell-specific deletion of Gata4. Tie2 lineage-traced mice were used as controls versus lineage-traced Ga-ta4-deleted mice with a continuous tamoxifen regimen, again beginning after weaning ( Figure 4A and 4B) . It is remarkable that after 2 months of tamoxifen, Gata4deleted endothelial cells showed a ≈2-fold increase in Tie2-eGFP + in the heart (Figure 4C and 4D) with a significant shift from CD31 high-expressing to CD31 low-expressing cells by flow cytometry (Figure 4G and 4H), suggesting a less differentiated state. Adult endothelial cell-specific deletion of Gata4 also resulted in the greater presence of CD45 + cells in the heart (Figure 4E and 4F ). In addition, 5-ethynyl-2ʹ-deoxyuridine staining of cardiac sections showed a 3-fold increase in endothelial cell-specific proliferation ( Figure 4I ). Skeletal muscle showed similar results with a shift toward CD31 low-expressing cells and increased 5-ethynyl-2ʹdeoxyuridine staining ( Figure IIIA and IIIB in the onlineonly Data Supplement). Together, these data suggest that loss of Gata4 in adult endothelial cells alters their differentiated state and produces greater proliferation and leukocyte diapedesis.
To probe even further into the hypothesis that deletion of Gata4 from Kit allele lineage-derived endothelial cells is the primary reason for enhanced bone marrow-derived leukocyte fusion with endogenous cardiomyocytes, we used the Kit MCM allele together with the Tie2 CreERT2 transgene in Gata4 fl/fl R26 eGFP mice given continuous tamoxifen ( Figure 5A and 5B) . Unfortunately, the Tie2 CreERT2 transgene is not active in bone marrow; hence, the Kit MCM allele is needed to label fusigenic immune cells, even though both Cre alleles would inactivate Gata4 within endothelial cells ORIGINAL RESEARCH ARTICLE of the heart ( Figure 5C ). The data again showed significantly greater rates of eGFP + -fused cardiomyocytes with Kit MCM allele-mediated deletion of Gata4, and that enhanced deletion of Gata4 from essentially all endogenous cardiac endothelial cells with the Tie2 CreERT2 transgene doubled the number of fused cardiomyocytes ( Figure 5D and 5E). To show this even more conclusively, bone marrow transplantation was performed between a R26 mT donor mouse and a Tie2 CreERT2 Gata4 fl/fl R26 eGFP recipient mouse. In this manner, the recipient mice only have Tie2 CreERT2 causing Gata4 deletion in adult endothelial cells without deletion of Gata4 from bone marrow-derived immune cells or endothelial progenitors. The data again show an enhanced rate of mTomato + -fused cardiomyocytes, indicating that the effect is exclusively attributable to defects within endogenous endothelial cells of the heart when Gata4 is deleted ( Figure 5G and 5H) .
Ex Vivo and Developmental Analysis of Gata4-Deleted Endothelial Cells
Isolation and culturing of endothelial cells from these genetically modified mouse hearts grossly showed that Gata4-replete cells form a typical cobblestone monolayer, whereas Gata4-deleted cells are less adherent and show a more torturous morphology ( Figure 6A ). Analysis of cell culture supernatant showed an increase in secretion of angiopoietin-2 and decreased VEGF-A from Gata4-deleted endothelial cells, which suggests a vascular-regressive state ( Figure 6B and 6C) . 43, 44 Endothelial cells mixed with Matrigel from these mice were subcutaneously injected into wild-type recipient mice to evaluate vascular tube formation with or without Gata4 deletion ( Figure 6D ). After 2 weeks, Matrigel plugs were collected and analyzed by confocal microscopy, which showed a limited ability of Gata4-deleted endothelial 
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cells to form differentiated vascular networks in comparison with Gata4-replete cells using z-stacked confocal microscopy ( Figure 6E ). Previously, embryonic endothelial-specific deletion of Gata4 with a constitutive Tie2-Cre transgene demonstrated late embryonic or perinatal lethality because of defective epithelial-to-mesenchymal transition and improper heart valve formation. 45 Here, we also observed embryonic lethality with a constitutive Kit Cre allele to delete Gata4. More specifically, constitutive Kit Cre Gata4 fl/fl mice were found to be hemorrhagic at embryonic day 11.5 with noticeable areas of blood pooling and defective vasculogenesis, leading to embryonic lethality ( Figure 6F ). Constitutive Cdh5 Cre (endothelial cell-specific cadherin 5 gene promoter)-mediated deletion of Gata4 also produced embryonic lethality at the same time (data not shown). Taken together, these results suggest that Kit allele-derived cells critically underlie early hemangioblast progenitor cell activity during development and that Gata4 is essential in these cells for proper vascular development.
Development of the superficial vascular plexus in the neonatal mouse eye begins at birth, with radial outgrowth of endothelial vessels reaching the retinal edge by p8. 46 To test the role of Gata4 in retinal vascularization, Tie2-dependent lineage-traced mice were injected with tamoxifen at p0 and harvested at p8 for cardiac phenotyping and retinal angiogenesis (Figure 6G ). Tie2 CreERT2 Gata4 fl/fl mice were underdeveloped in comparison with Gata4 fl/fl controls with significantly reduced heart size ( Figure 6H ) and improper patterning of both micro-and macrovasculature in the retina in comparison with Tie2 CreERT2 R26 eGFP controls ( Figure 6I ). Together, these findings suggest that, in addition to 
Gene Expression Alterations in Adult Gata4-Deficient Endothelial Cells
To elucidate the molecular basis for Gata4-dependent regulation of endothelial cell differentiation, global RNA sequencing was performed from cardiac endothelial cells isolated from Tie2 CreERT2 R26 eGFP Gata4 fl/fl mice versus Tie2 CreERT2 R26 eGFP controls (Figure 7) . Cells doublepositive for endogenous Tie2 lineage tracing (eGFP + ) and fluorescently labeled for CD31 were obtained by fluorescence-activated cell sorting at 8 weeks of age after 4 weeks of tamoxifen induction. Bioinformatics analysis of the data showed a gene expression signature in which many of the top categories are related to previously known partners and targets of Gata4, and genes related to the function and maintenance of the vasculature (Figure 7) . Although signature endothelialdefining genes 47 (Cdh5, Edn1, Kdr, Pecam1, S1pr1, Vwf) were largely unchanged, well-established regulatory partners of Gata4, including Fog2 (Zfpm2), 48, 49 Hand2, 50 Tbx20, 51 Dkk3, 52 Mlc2a (Mly7), 53 Sox9, 54 and Klf15, 55 were significantly downregulated. A variety of putatively Gata4-regulated genes were also identified using the Harmonizome database, 56 many of which have evidence for vascular regulation. For example, Figf (Vegfd), a predicted target of Gata4, was downregulated in this study and has a known role in endothelial cell regulation. 57 A host of genes related in angiogenesis and extracellular matrix formation were impacted with Gata4 deletion including downregulation of Itgb4, Mmp2, Timp2, Vcam1, and Vcan and upregulation of Apold1 and Has3 (Figure 7) . In addition, a number of genes related to the cell cycle in endothelial cells were upregulated, such as E2f7, Egr1/2/3, Esm1, and Plk3. Verification of mRNA expression differences was performed for most of these gene changes by quantitative reverse transcription polymerase chain reaction, showing consistency with the patterns found by RNA sequencing analysis ( Figure IV in the online-only Data Supplement). Together, these gene expression data suggest a global impact of Gata4 deletion on the endothelial cell differentiation gene program, helping to validate the observed differences in proliferation, permeability, and maturation.
DISCUSSION
Here, we used a genetic approach to determine if the very low level of presumed new cardiomyocyte generation in the heart from the Kit lineage really occurs, es- 
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pecially because it was recently reported that adult cardiac Kit-dependent CPCs never truly transdifferentiate into cardiomyocytes. 24 Indeed, deletion of Gata4 and Gata6 simultaneously from Kit lineage cells did not reduce the apparent rate of cardiomyocyte labeling in the heart by genetic lineage tracing, and in fact caused as much as a 10-fold increase. Because Gata4/6 are lacking, it is even more unlikely that new cardiomyocytes could be created from a progenitor cell source, even embryonic stem cells. 27 This consideration, along with the very dramatic increase in cell fusion we observed in the current study, suggest that most past results reporting a minor contribution of cardiomyocytes from the Kit lineage are likely because of cellular fusion between lineage-traced immune cells and host endogenous cardiomyocytes, or from ectopic induction of the Kit MCM allele in cardiomyocytes. 24 Indeed, our past results, which were subtracted for cellular fusion effects, still showed apparent de novo cardiomyocyte production at ≈1 in 17 000, but, as suggested in the recent literature, this likely reflects ectopic activation of the Kit Cre allele within rare cardiomyocytes. 24, 58 Hence, it could be argued that Kit lineage-traced cells from any source, whether bone marrow or endogenous to the heart, essentially lack all cardiomyocyte transdifferentiation ability. In attempting to understand how Gata4 deletion from the Kit lineage produced an apparent 10-fold increase in eGFP + cardiomyocytes, we uncovered an essential role for this transcription factor in regulating the endothelial cell gene program. Although endothelial cell-specific deletion of Gata4 was shown to cause developmental lethality because of alterations in endothelial cell activity in the cardiac cushions and newly developing heart valves, 45 a role for Gata4 in adult cardiac vascular maintenance had not been previously explored. Gata4 was also recently identified as a master regulator of liver sinusoidal endothelial cells, determining their organ specificity and requirement in liver development. 59 In addition, in this transition from sinusoidal to capillary formed vascular networks in the liver, the authors observed a distinct shift in CD31 low cells to CD31 high cells. 59 Conversely, we observed a shift toward more permeable vasculature and greater CD-31 low cells (less differentiated) in the heart and skeletal muscle with deletion of Gata4, but this effect was not observed in the liver or lung of our study using Tie2 CreERT2 (data not shown).
We observed that Gata6 deletion in both Kit allele and endothelial lineages did not overtly alter the angiogenic and vascular processes as shown with Gata4 deletion. Indeed, we observed that constitutive Kit Creexpressing Gata6 fl/fl -deleted mice were not lethal and, when lineage-traced through development to 5 months of age, did not show increases in eGFP + cardiomyocytes. Endothelial cell-specific deletion of Gata6 with the inducible Tie2-specific Cre mice also did not demonstrate an increase in CD31 + cells or increased vascular permeability, suggesting that only Gata4 plays a specific role in regulating the expression of genes involved in endothelial cell biology. We previously observed a similar paradigm at the level of the cardiomyocyte in which angiogenic genes in this cell type were preferentially regulated by Gata4 over Gata6. 29 Currently, we speculate that Gata4 is important in endothelial cell maturation/differentiation largely because of the observed ex vivo defective tube formation and the appearance of CD31 low endothelial cells in Tie2 CreERT2 transgene-mediated Gata4-deleted mice. The overall increase in CD31 + and Tie2 lineage-traced eGFP + cells could be a compensatory response of the cardiac vasculature because of the inability of endothelial cells to maintain secure junctions when Gata4regulated gene expression is compromised. Thus, new endothelial cells are formed as an attempt to bolster the vasculature, yet leukocytes are still able to infiltrate more easily, giving greater fusion events with endogenous cardiomyocytes. Alternatively, poorly differentiated endothelial cells resulting from the deletion of Gata4 generate a tissue injury-like signal in these cells that recruits leukocytes and makes them more active. Overall, our results suggest that Gata4 could be used as a therapeutic leverage point in affecting endothelial cell biology for selective therapeutic approaches in humans.
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